Kris M. Mahadeo
Experienced in Histiocytosis

Dr. Kris M. Mahadeo

Pediatric Hematology Oncology
Duke Health
Duke Children's Health Center Bone Marrow Transplant Clinic
2301 Erwin Rd, 
Durham, NC 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
18 Years of Experience
Experienced in Histiocytosis
Duke Health
Duke Children's Health Center Bone Marrow Transplant Clinic
2301 Erwin Rd, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I care for patients and families seeking bone marrow transplants, cellular therapies, and gene therapies for high-risk cancers, genetic and metabolic disorders, and primary immune deficiencies. I work closely with a comprehensive team to ensure the best long-term outcomes and quality of life. I am attentive to the needs of my patients, as well as their caregivers and families. In my spare time, I enjoy traveling and exploring new cultures.

Dr. Mahadeo is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Hepatic Venoocclusive Disease with Immunodeficiency, Leukemia, Infantile Neutropenia, Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 15 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Histiocytosis.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NY
Board Certifications
American Board Of Pediatrics, General Pediatrics
American Board Of Pediatrics, Pediatric Hematology-Oncology
Fellowships
Pediatric Transplantation and Cellular Therapy, Duke University, Pediatric Hematology-Oncology, Albert Einstein College of Medicine - Montefiore Medical Center
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

Duke Children's Health Center Bone Marrow Transplant Clinic
2301 Erwin Rd, Durham, NC 27710

Additional Areas of Focus

Dr. Mahadeo has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Enrollment Status: Recruiting
Publish Date: November 24, 2025
Intervention Type: Drug
A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants With Severe Combined Immunodeficiency (SCID) Receiving TCRαβ+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC)
A Randomized Trial of Low Versus Moderate Exposure Busulfan for Infants With Severe Combined Immunodeficiency (SCID) Receiving TCRαβ+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC)
Enrollment Status: Active_not_recruiting
Publish Date: November 21, 2025
Intervention Type: Drug, Device
Study Drug: Busulfan
Study Phase: Phase 2
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases
Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Phase: Phase 2
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Enrollment Status: Available
Publish Date: August 15, 2025
Intervention Type: Biological
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and Adolescent-Young Adults Patients With High Risk Solid Tumors
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric and Adolescent-Young Adults Patients With High Risk Solid Tumors
Enrollment Status: Terminated
Publish Date: June 29, 2025
Intervention Type: Biological, Drug, Procedure
Study Drugs: Cyclosporine, Etoposide, Fludarabine Phosphate, Lapine T-Lymphocyte Immune Globulin, Melphalan, Mycophenolate Mofetil, Tacrolimus, Thiotepa
Study Phase: Phase 2
A Pilot Study of Allogeneic Hematopoietic Cell Transplantation for Patients With High Grade Central Nervous System Malignancies
A Pilot Study of Allogeneic Hematopoietic Cell Transplantation for Patients With High Grade Central Nervous System Malignancies
Enrollment Status: Withdrawn
Publish Date: October 26, 2024
Intervention Type: Biological, Drug, Procedure
Study Drugs: Etoposide, Fludarabine Phosphate, Lapine T-Lymphocyte Immune Globulin, Melphalan, Mycophenolate Mofetil, Tacrolimus, Thiotepa
Study Phase: Phase 1
Pre-Transplant Immunosuppression and Related Haploidentical Hematopoietic Cell Transplantation for Patients With Severe Hemoglobinopathies
Pre-Transplant Immunosuppression and Related Haploidentical Hematopoietic Cell Transplantation for Patients With Severe Hemoglobinopathies
Enrollment Status: Withdrawn
Publish Date: October 24, 2024
Intervention Type: Drug, Biological, Procedure
Study Drugs: Bortezomib, Busulfan, Cyclophosphamide, Dexamethasone, Fludarabine Phosphate, Lapine T-Lymphocyte Immune Globulin, Mycophenolate Mofetil, Rituximab, Tacrolimus
Study Phase: Early Phase 1
Phase I/II Study of CaspaCIDe T Cells (BPX-501; Rivogenlecleucel) From an HLA Partially Matched Family Donor After Negative Selection of TCRαβ+ T Cells in Paediatric Patients Affected by Haematological Disorders
Phase I/II Study of CaspaCIDe T Cells (BPX-501; Rivogenlecleucel) From an HLA Partially Matched Family Donor After Negative Selection of TCRαβ+ T Cells in Paediatric Patients Affected by Haematological Disorders
Enrollment Status: Terminated
Publish Date: September 29, 2023
Intervention Type: Biological, Drug
Study Drugs: Rivogenlecleucel, Rimiducid
Study Phase: Phase 1/Phase 2
Phase I/II Study of CaspaCIDe® T Cells From an HLA-Partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders
Phase I/II Study of CaspaCIDe® T Cells From an HLA-Partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders
Enrollment Status: Active_not_recruiting
Publish Date: July 12, 2022
Intervention Type: Biological, Drug
Study Drugs: BPX-501 T Cells, Rimiducid
Study Phase: Phase 1/Phase 2
Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Allogeneic Stem Cell Transplantation of NiCord®, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Enrollment Status: Completed
Publish Date: May 20, 2022
Intervention Type: Drug
Study Drug: NiCord Cord Blood Graft
Study Phase: Phase 1/Phase 2
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
A Single-arm, Prospective Study of Remestemcel-L, Ex-vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Enrollment Status: Completed
Publish Date: March 17, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Enrollment Status: No_longer_available
Publish Date: March 14, 2022
Intervention Type: Drug
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
A Prospective Observational Study for the Long-term Follow-up of Subjects Previously Enrolled in Selected Clinical Studies of CMX001.
Enrollment Status: Terminated
Publish Date: May 17, 2019
Intervention Type: Drug
View 12 Less Clinical Trials

109 Total Publications

Erratum to <[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>.
Erratum to <[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>.
Journal: Transplantation and cellular therapy
Published: October 09, 2025
View All 109 Publications
Similar Doctors
Experienced in Histiocytosis
Dr. David E. Kram
Pediatric Hematology Oncology
Experienced in Histiocytosis
Dr. David E. Kram
Pediatric Hematology Oncology
101 Manning Dr, 
Chapel Hill, NC 
 (9.7 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances

David Kram is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Kram is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Glioma, Rhabdoid Tumor, Medulloblastoma, Reticulohistiocytoma, and Bone Marrow Aspiration.

Experienced in Histiocytosis
Dr. Stuart H. Gold
Pediatric Hematology Oncology
Experienced in Histiocytosis
Dr. Stuart H. Gold
Pediatric Hematology Oncology
101 Manning Dr, 
Chapel Hill, NC 
 (9.6 miles away)
919-966-4131
Languages Spoken:
English
See accepted insurances

Stuart Gold is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Gold is rated as an Experienced provider by MediFind in the treatment of Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Ewing Sarcoma, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.

Jennifer Rothman
Experienced in Histiocytosis
Dr. Jennifer Rothman
Pediatric Hematology Oncology
Experienced in Histiocytosis
Dr. Jennifer Rothman
Pediatric Hematology Oncology
2100 Erwin Rd, 
Durham, NC 
 (0.2 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jennifer Rothman is a Pediatric Hematologist Oncology provider in Durham, North Carolina. Dr. Rothman is rated as a Distinguished provider by MediFind in the treatment of Histiocytosis. Her top areas of expertise are Pyruvate Kinase Deficiency, Anemia, Hemolytic Anemia, Congenital Hemolytic Anemia, and Splenectomy.

VIEW MORE HISTIOCYTOSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mahadeo's expertise for a condition
ConditionClose
    • Distinguished
    • Bone Marrow Transplant
      Dr. Mahadeo is
      Distinguished
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Hepatic Venoocclusive Disease with Immunodeficiency
      Dr. Mahadeo is
      Distinguished
      . Learn about Hepatic Venoocclusive Disease with Immunodeficiency.
      See more Hepatic Venoocclusive Disease with Immunodeficiency experts
    • Advanced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Mahadeo is
      Advanced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Anemia
      Dr. Mahadeo is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    • Graft Versus Host Disease (GvHD)
      Dr. Mahadeo is
      Advanced
      . Learn about Graft Versus Host Disease (GvHD).
      See more Graft Versus Host Disease (GvHD) experts
    • Hemoglobinopathy
      Dr. Mahadeo is
      Advanced
      . Learn about Hemoglobinopathy.
      See more Hemoglobinopathy experts
    • Hemolytic Anemia
      Dr. Mahadeo is
      Advanced
      . Learn about Hemolytic Anemia.
      See more Hemolytic Anemia experts
    • Infantile Neutropenia
      Dr. Mahadeo is
      Advanced
      . Learn about Infantile Neutropenia.
      See more Infantile Neutropenia experts
    View All 8 Advanced Conditions
    • Experienced
    • Aase Syndrome
      Dr. Mahadeo is
      Experienced
      . Learn about Aase Syndrome.
      See more Aase Syndrome experts
    • Acquired Amegakaryocytic Thrombocytopenia
      Dr. Mahadeo is
      Experienced
      . Learn about Acquired Amegakaryocytic Thrombocytopenia.
      See more Acquired Amegakaryocytic Thrombocytopenia experts
    • Adult Soft Tissue Sarcoma
      Dr. Mahadeo is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Adult T-Cell Leukemia
      Dr. Mahadeo is
      Experienced
      . Learn about Adult T-Cell Leukemia.
      See more Adult T-Cell Leukemia experts
    • Aplastic Anemia
      Dr. Mahadeo is
      Experienced
      . Learn about Aplastic Anemia.
      See more Aplastic Anemia experts
    • Bone Graft
      Dr. Mahadeo is
      Experienced
      . Learn about Bone Graft.
      See more Bone Graft experts
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.